Literature DB >> 15196082

Infection with human herpesvirus 6 after kidney-pancreas transplant.

Natividad Benito1, M José Ricart, Tomás Pumarola, M Angeles Marcos, Federico Oppenheimer, Asunción Moreno Camacho.   

Abstract

We describe the first known case of symptomatic infection resulting from human herpesvirus-6 (HHV-6) in simultaneous pancreas-kidney transplant recipients. The role of HHV-6 in solid-organ transplant recipients is not well defined. In hematopoietic stem cell transplantation (SCT) HHV-6 may cause fever, rash, myelosuppression, interstitial pneumonitis, and encephalitis.

Entities:  

Mesh:

Year:  2004        PMID: 15196082     DOI: 10.1111/j.1600-6143.2004.00449.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

Review 1.  Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation.

Authors:  Ann M Leen; Tamara Tripic; Cliona M Rooney
Journal:  Expert Opin Biol Ther       Date:  2010-03       Impact factor: 4.388

Review 2.  Viral infection in renal transplant recipients.

Authors:  Jovana Cukuranovic; Sladjana Ugrenovic; Ivan Jovanovic; Milan Visnjic; Vladisav Stefanovic
Journal:  ScientificWorldJournal       Date:  2012-05-02

3.  Dominance of variant A in human herpesvirus 6 viraemia after renal transplantation.

Authors:  Eszter Csoma; Beáta Mészáros; Tamás Gáll; László Asztalos; József Kónya; Lajos Gergely
Journal:  Virol J       Date:  2011-08-15       Impact factor: 4.099

Review 4.  Virus-Associated Nephropathies: A Narrative Review.

Authors:  Christophe Masset; Paul Le Turnier; Céline Bressollette-Bodin; Karine Renaudin; François Raffi; Jacques Dantal
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

5.  HHV-6 infection in a pediatric kidney transplant patient.

Authors:  Foteini Koukourgianni; Valérie Pichault; Aurélia Liutkus; Yves Gillet; Bruno Ranchin; Guillaume Mestrallet; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2009-07-07       Impact factor: 3.651

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.